Communiqués Scilex Holding Company

Actions

SCLX

US80880W2052

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 08/09/2026			Varia. 5j.	Varia. 1 janv.
5,370 ^USD	-0,83 %		-0,56 %	-55,98 %

14/08	Scilex Holding Company publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
06/07	Scilex accepte de céder pour 100 millions de dollars d'actions nouvelles au groupe kazakh iHolding	MT

Communiqués

06/08	Aveva Drug Delivery Systems Prevails on Appeal, Federal Circuit Affirms Non-Infringement of ZTlido(R) Patents - Prepares for an Imminent Launch of its Generic Product with 180 Day Exclusivity	AQ
07/07	Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP	AQ
06/07	Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026	AQ
06/07	Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP	AQ
16/06	Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens to List on Biconomy Exchange as Early as June 23, 2026	AQ
12/06	Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities	AQ
05/06	Scilex Holding Company Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock	AQ
04/06	Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities	AQ
22/05	Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026	AQ
04/05	Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026	AQ
20/04	Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026	AQ
30/01	Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets	AQ
02/01	Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel	AQ
23/12	Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.	AQ
25/11	Scilex : Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds	PU
24/11	Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds	AQ
12/11	Scilex Holding Company Announces that the Board of Directors of Datavault AI Inc. Has Approved the Distribution of a Dream Bowl 2026 Meme Coin to All Eligible Scilex and Datavault AI Stockholders of Record	AQ
05/11	Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information	AQ
03/11	Scilex Holding Company Announces the Sponsorship of Dream Bowl 2026 and Set a Record Date of November 14, 2025 for Its Shareholders to Receive Dream Bowl 2026 Meme Coin Distributed by DataVault AI	AQ
01/10/25	Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase	AQ
29/09/25	Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI	AQ
25/09/25	Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI	AQ
25/09/25	Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bitcoin	AQ
24/09/25	Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management	AQ
23/09/25	Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin	AQ